shopping cart
nothing in cart
 
browse by subject
new releases
best sellers
sale books
browse by author
browse by publisher
home
about us
upcoming events
Sep 18th - The Forensic Dual Diagnosis Specialty Service Conference II: Exploring Risk & Recovery in Dual Diagnosis [CAMH Forensic Dual Diagnosis Specialty Service]
Sep 20th - Teenagers Today: What you need to know - Session 1: Signs, Symptoms and Risk Factors of Suicide. Session 2: How to Engage Adolescents in Psychotherapy. [SickKids CCMH Learning Institute]
Sep 20th - OACCPP 41st Annual Conference & AGM: Trauma, Resilience & Adaptability [OACCPP: the Ontario Association of Consultants, Counsellors, Psychometrists and Psychotherapists]
Sep 20th - Building Recovery Capital in Canada: Building on Our Strengths to Overcome Addiction - Saskatchewan [Last Door Recovery Society]
Sep 23rd - Mental Health for All CMHA National Conference: Connection Interrupted: Restoring Mental Health in a Fractured World [Canadian Mental Health Association]
schools agencies and other institutional orders (click here)
Cognitive Impairment in Major Depressive Disorder: Clinical Relevance, Biological Substrates, and Treatment Opportunities
McIntyre, Roger S. and Danielle S. Cha (Eds)
Cambridge University Press / Hardcover / 2016-04-01 / 1107074584
Psychiatry
reg price: $144.95 our price: $ 115.96
In Stock (Ships within one business day)

Major Depressive Disorder (MDD) is the leading cause of disability globally in both developed and developing nations. The staggering economic costs attributable to MDD are largely a consequence of impairment in role function. Evidence indicates that disturbance in the domain of cognitive function in individuals with MDD is the principle determinant of health outcome. This is the first book to comprehensively explore the domain of cognition in MDD. The literature describing cognitive dysfunction is reviewed with particular focus on clinical determinants, pathophysiology and causative factors. The patient subpopulations most susceptible are defined. A summary of contemporary assessment tools for research and clinical purposes is provided. Multimodality treatments and prevention strategies are described. This book is an invaluable resource for psychiatrists, neuropsychologists and other members of the mental health team, as well as for policy makers, vocation rehabilitation experts, disability providers and other stakeholders interested in improving health outcomes in MDD.

The first book to bring together all aspects related to cognition in MDD
Contributors are the world's experts on the topic of cognition in MDD
Covers recognition, prevention, measurement and management
Recommends neuropsychological, psychological and pharmacological approaches to management

Table of Contents

Preface
Part I. Clinical Relevance of Cognitive Dysfunction in Major Depressive Disorder:
1. Does cognitive dysfunction predate the onset of incident depression? Julia Buthmann, Danielle S. Cha and Roger S. McIntyre
2. Understanding the importance of cognitive dysfunction and cognitive change in major depressive disorder Paul Maruff and Judith Jaeger
3. Cognitive dysfunction in adults with major depressive disorder Beatrice Bortolato, Cristiano Kohler and Andre Carvalho
4. Cognition in MDD implications for primary care Larry Culpepper
5. Neurocognition in pediatric depression Dwight Newton, Melanie Naiberg and Benjamin Goldstein
6. Neuroanatomy of cognition in major depressive disorder (hot and cold) Guy M. Goodwin
7. Hot and cold cognition in major depressive disorder Oliver Robinson, Jonathan Rosier and Barbara Sahakian
8. Social cognition and emotional processing in major depressive disorder Philippe Fossati and Sophie Hinfray
9. The role of social cognition in major depressive disorder Bernhard Baune and Michael Weightman
10. Are cognitive deficits in major depressive disorder progressive? Philip Gorwood and Marie Laure Clery-Melin
11. Implications of cognitive impairments on functional outcomes in major depressive disorder Tracy L. Greer and Cassandra R. Hatt
Part II. Underlying Biological Substrates Associated with Cognitive Dysfunction in Major Depressive Disorder:
12. Cognition and biomarkers in major depressive disorder (MDD): endophenotype or epiphenomenon? Shane McInerney, Philip Gorwood and Sidney Kennedy
13. Inflammation and cognition in major depressive disorder Bernhard Baune
14. HPA axis and cognitive dysfunction in mood disorders Rebecca Strawbridge and Allan H. Young
15. White matter neurobiology and cognitive dysfunction in major depressive disorder Geoffrey Chern-Yee Tan and Kang Sim
16. Insulin resistance and implications for hippocampal volume/function the default mode network Heather A. Kenna, Tonita E. Wroolie, Danielle R. Balzafiore and Natalie L. Rasgon
Part III. Evaluating Cognitive Dysfunction in Major Depressive Disorder:
17. Measuring the mind: detecting cognitive deficits and measuring cognitive change in patients with depression John Harrison
18. Subjective measures of cognitive dysfunction in major depressive disorder Raymond Lam
Part IV. Treatment Opportunities for Ameliorating Cognitive Dysfunction in Major Depressive Disorder:
19. Neuroscience of functional outcomes and treatment targets in major depressive disorder Lisanne M. Jenkins, Amy Peters, Rachel H. Jacobs and Scott A. Langenecker
20. Treatment of cognitive dysfunction in adults with major depressive disorder Roger S. McIntyre, Kahlood Syeda and Danielle S. Cha
21. A novel treatment targeting cognitive dysfunction in mood disorders Kamilla W. Miskowiak
22. Cognitive remediation for major depressive disorder Christopher Bowie
23. Exercise and cognition Guy Faulkner, Mark Duncan and Mehala Subramaniapillai
Index.

Contributors:

Julia Buthmann, Danielle S. Cha, Roger S. McIntyre, Paul Maruff, Judith Jaeger, Beatrice Bortolato, Cristiano Kohler, Andre Carvalho, Larry Culpepper, Dwight Newton, Melanie Naiberg, Benjamin Goldstein, Guy M. Goodwin, Oliver Robinson, Jonathan Rosier, Barbara Sahakian, Philippe Fossati, Sophie Hinfray, Bernhard Baune, Michael Weightman, Philip Gorwood, Marie Laure Clery-Melin, Tracy L. Greer, Cassandra R. Hatt, Shane McInerney, Sidney Kennedy, Rebecca Strawbridge, Allan H. Young, Geoffrey Chern-Yee Tan, Kang Sim, Heather A. Kenna, Tonita E. Wroolie, Danielle R. Balzafiore, Natalie L. Rasgon, John Harrison, Raymond Lam, Lisanne M. Jenkins, Amy Peters, Rachel H. Jacobs, Scott A. Langenecker, Kahlood Syeda, Kamilla W. Miskowiak, Christopher Bowie, Guy Faulkner, Mark Duncan, Mehala Subramaniapillai

About the Editors:

Roger S. McIntyre is Head of the Mood Disorders Psychopharmacology Unit, University Health Network, and Professor of Psychiatry and Pharmacology, University of Toronto, ON, Canada.

Danielle S. Cha is a Researcher at the Institute of Medical Science, University of Toronto, and the Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.


Caversham Booksellers
98 Harbord St, Toronto, ON M5S 1G6 Canada
(click for map and directions)
All prices in $cdn
Copyright 2019

Phone toll-free (800) 361-6120
Tel (416) 944-0962 | Fax (416) 944-0963
E-mail info@cavershambooksellers.com
Hours: 9-6 M-W / 9-7 Th-F / 10-6 Sat / 12-5 Sun EST

search
Click here to read previous issues.
related events
also at 68th CPA Convention
Canadian Psychiatric Association 2018 annual confe
authors
McIntyre, Roger S
other lists
68th CPA Conference Features 2018
Cambridge University Press
Canadian Authors
Login Canada 2016 Clinical Psych Catalogue
Psychiatry
Psychiatry - Canadian Authors
Toronto Authors
University Presses